Germany's lower house of parliament passes healthcare reform

Germany’s lower house approved a bill to overhaul the creaking health insurance system, a move facing fierce opposition from drug companies. Insurers’ pricing changes could lead to tougher pricing measures that may pressure profitability and reduce industry investment. Sector impact is likely as the legislation could alter future reimbursement and revenues for pharma.

Analysis

Germany’s lower house approved a bill to overhaul the creaking health insurance system, a move facing fierce opposition from drug companies. Insurers’ pricing changes could lead to tougher pricing measures that may pressure profitability and reduce industry investment. Sector impact is likely as the legislation could alter future reimbursement and revenues for pharma.